Aledade, a US-based healthcare management technology provider backed by internet and technology conglomerate Alphabet, has raised $23m from investors including venture capital firms Venrock and Biomatics Capital, Axios has reported.
The figure was revealed in a regulatory filing that shows the company is targeting a $28m final close for the round, but Axios reported the identity of the investors.
Founded in 2014, Aledade has developed a platform for primary care physicians that provides them with the tools to setup doctor-led accountable care organisations, which are networks that delivery coordinated care to patients.
Aledade works with commercial and public health plans including the Medicare Shared Saving Program, Blue Cross Blue Shield and the West Virginia Public Employees Insurance Agency to provide care to patients in their programs.
The company had previously raised $20m in a January 2017 series B round led by Biomatics Capital that included Alphabet subsidiary GV as well as Maryland Venture Fund, Venrock and Arch Venture Partners.
Aledade added $20.2m from undisclosed investors two months later, according to a securities filing. Arch Venture Partners and Venrock had provided $30m in funding for Aledade in 2015 after the investing $4.5m the previous year.